NR4A1 and cancer: Nur77 promotes cell proliferation in Daoy medulloblastoma cells, but miR-124 reduces it, in part by targeting Nur77. This study supports the use of miRNA mimics to treat cancers, especially those in which Nur77 has an oncogenic role.